Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 4, 2025, 4:00 PM EST
Rosetta Genomics Market Cap
Rosetta Genomics has a market cap or net worth of $6 as of December 5, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
6.00
Enterprise Value
n/a
Revenue
2.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 27, 2007, Rosetta Genomics's market cap has decreased from 82.42M to 6.00, a decrease of -100.00%. That is a compound annual growth rate of -58.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 6.00 | - |
| Dec 27, 2024 | 6.00 | -98.99% |
| Dec 29, 2022 | 593.00 | - |
| Dec 31, 2021 | 593.00 | -99.50% |
| Dec 31, 2020 | 118.60K | 566.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 364.92M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |